Synergistic antifungal effect of fluconazole and human polymorphonuclear leukocytes on Paracoccidioides brasiliensis: effect of interferon-gamma and granulocyte-macrophage colony-stimulating factor

References

• Kurita N, Oarada M, Ito E, et al. Antifungal activity of human polymorphonuclear leucocytes against yeast cells of Paracocci-dioides brasiliensis. Med Mycol 1999; 37: 261–267.
   PubMed Web of Science ®Google Scholar
• Kurita N, Oarada M, Miyaji M, et al. Effect of cytokines on antifungal activity of human polymorphonuclear leucocytes against yeast cells of Paracoccidioides brasiliensis. Med Mycol 2000; 38: 177–182.
   PubMed Web of Science ®Google Scholar
• Kurita N, Biswas SK, Oarada M, et al. Fungistatic and fungicidal activities of murine polymorphonuclear leucocytes against yeast cells of Paracoccidioides brasiliensis. Med Mycol 1999; 37: 19–24.
   PubMed Web of Science ®Google Scholar
• Tucker RM, Williams PL, Arathoon EG, et al. Pharmacoki-netics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis. Antimicrob Agents Chemother 1988; 32: 369–373.
   PubMed Web of Science ®Google Scholar
• Sugar AM, Sauders C. Oral fluconazole as suppressive therapy in disseminated cryptococcosis in patients with acquired immunodeficiency syndrome. Am J Med 1988; 85: 481–489.
   PubMed Web of Science ®Google Scholar
• Stevens DA, Brummer E, McEwen JO, et al. Comparison of fluconazole and ketoconazole in experimental murine blasto-mycosis. Rev Infect Dis 1990; 12 (Suppl. 3): S304–306.
   Google Scholar
• Hahn RC, Hamdan JC. Effects of amphotericin B and three azole derivatives on the lipids of yeast cells of Paracoccidioides brasiliensis. Antimicrob Agents Chemother 2000; 44: 1997–2000.
   PubMedGoogle Scholar
• Saag MS, Dismukes WE. Azole antifungal agents: emphasis on new triazoles. Antimicrob Agents Chemother 1988; 32: 1–8.
   PubMed Web of Science ®Google Scholar
• Martinez R, Malta MHB, Verceze AV, et al. Comparative efficacy of fluconazole and amphotericin B in the parenteral treatment of experimental paracoccidioidomycosis in the rat. Mycopathologia 1999; 146: 131–134.
   Google Scholar
• Diaz M, Negroni R, Montero-Gei F, et al. A Pan-American 5-year study of fluconazole therapy for deep mycosis in the immunocompetent host. Pan-American Study Group. Clin Infect Dis 1992; 14 (Suppl. 1): S68–76.
   Google Scholar
• Ansari AM, Gould IM, Douglas JO. High dose oral fluconazole for oropharyngeal candidiasis in AIDS. J Antimicrobial Che-mother 1990; 25: 720–721.
   Google Scholar
• Brummer E, Stevens DA. Synergy of human neutrophils with fluconazole in killing Candida species. Mycopathologia 1996; 134: 115–120.
   PubMed Web of Science ®Google Scholar
• Naiff RD, Ferreira LCL, Barrett TV, et al. Paracoccidioidomi-cose enzootica em tatus (Dasypus novemcinctus) no estado do Para. Rev Inst Med Trop Scio Paulo 1986; 28: 19–27.
   PubMed Web of Science ®Google Scholar
• Kurita N, Sano A, Coelho KIR, et al. An improved culture medium for detecting live yeast phase cells of Paracoccidioides brasiliensis. J Med Vet Mycol 1993; 31: 201–205.
   PubMedGoogle Scholar
• Brummer E, Kurita N, Yoshida S, et al. Fungistatic activity of human neutrophils against Histoplasma capsulatum: correlation with phagocytosis. J Infect Dis 1991: 164: 158–162.
   PubMed Web of Science ®Google Scholar
• Brummer E, Stevens DA. Opposite effects of human mono-cytes, macrophages, and polymorphonuclear neutrophils on replication of Blastomyces dermatitidis in vitro. Infect Immun 1982; 36: 297–303.
   PubMedGoogle Scholar
• Kurita N, Sano A, Soares A, et al. Growth-promoting factors for yeast cells of Paracoccidioides brasiliensis. Mycoscience 1996. 37: 35–39.
   Google Scholar
• Pasko MT, Piscitelli SC, Van Slooten AD. Fluconazole: a new triazole antifungal agent. DICP, Annals Pharmacother 1990.24: 860–867.
   Google Scholar
• Brummer E, Kamei K, Miyaji M. Damage to yeast cells of Cryptococcus neoformans by voriconazole and fluconazole: a culture and microscopic study. Med Mycol 1998.36: 227–233.
   Google Scholar
• Humphrey MJ, Jevons S, Tarbit M H. Pharmacokinetic evalua-tion of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans. Antimicrob Agents Chemother 1985; 28: 648–653.
   Google Scholar
• Benard G, Neves CP, Gryschek RCB, et al. Severe juvenile type paracoccidioidomycosis in an adult. J Med Vet Mycol 1995; 33: 67–71.
   Google Scholar
• Karhawi ASK, Colombo AL, Salomao R. Production of IFN-,y is impaired in patients with paracoccidioidomycosis during active disease and is restored after clinical remission. Med Mycol 2000; 38: 225–229.
   Google Scholar
• Oliveira SJ, Mamoni RL, Musatti CC, et al. Cytokines and lymphocyte proliferation in juvenile and adult forms of paracoccidioidomycosis: comparison with infected and non-infected controls. Microbes Infect 2002; 4: 139–144.
   PubMed Web of Science ®Google Scholar
• Moscardi-Bacchi M, Brummer E, Stevens DA. Support of Paracoccidioides brasiliensis multiplication by human mono-cytes or macrophages: inhibition by activated phagocytes. J Med Microbiol 1994; 40: 159–164.
   Google Scholar
• Ruef C, Coleman DL. Granulocyte-macrophage colony-stimu-lating factor: pleiotropic cytokine with potential clinical useful-ness. Rev Infect Dis 1990; 12: 41–62.
   PubMedGoogle Scholar
• Magee DM, Wing EJ. Antigen-specific production of colony-stimulating factors by Listeria monocyto genes-immune L3T4-positive cells. J Infect Dis 1988; 157: 941–949.
   Google Scholar